Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation.
Ontology highlight
ABSTRACT: More than 700 pathogenic or probably pathogenic variations have been identified in the RYR1 gene causing various myopathies collectively known as "RYR1-related myopathies." There is no treatment for these myopathies, and gene therapy stands out as one of the most promising approaches. In the context of a dominant form of central core disease due to a RYR1 mutation, we aimed at showing the functional benefit of inactivating specifically the mutated RYR1 allele by guiding CRISPR-Cas9 cleavages onto frequent single-nucleotide polymorphisms (SNPs) segregating on the same chromosome. Whole-genome sequencing was used to pinpoint SNPs localized on the mutant RYR1 allele and identified specific CRISPR-Cas9 guide RNAs. Lentiviruses encoding these guide RNAs and th
SUBMITTER: Beaufils M
PROVIDER: S-EPMC11278293 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA